Endothelial injury: blood-vessel wall interactions.
Endothelial injury: blood-vessel wall interactions.
复制标题
内皮损伤:血管壁相互作用。
DOI:
10.1111/j.1749-6632.1982.tb25725.x
复制
发表时间:
1982
影响因子:
5.2
通讯作者:
Faggiotto,A
中科院分区:
文献类型:
--
作者:
Ross,R;Bowen-Pope,D;Raines,EW;Faggiotto,A
As has been discussed elsewhere in this volume, maintenance of endothelial integrity, including both structural and functional integrity, represents a key element in the response to injury hypothesis of atherosclerosis. This hypothesis suggests that the functional capacity of the endothelium may in some way be altered by the various factors that are associated with atherogenesis, and that this alteration leads to a sequence of cellular changes that culminate in the formation of the lesions. 1, 2 It is conceivable, therefore, that although" endothelial injury" may represent a common denominator in the process of atherogenesis, the sequence of events may be somewhat different in injury resulting from chronic hypercholesterolemia versus that which may occur as a result of cigarette smoking, diabetes, hypertension, or other factors that are known to be associated with an increased risk of atherosclerosis.The response to injury hypothesis suggests that whatever the changes in the endothelial cells, they ultimately lead to opportunities for interactions of at least two cells from the blood, the platelet and the monocytelmacrophage, with either the altered endothelium or the subendothelial connective tissue. These endothelial changes could also present opportunities for entry of constituents of the plasma into the artery wall in an uncontrolled fashion and, in the case of elevated low-density lipoproteins, may lead to the deposition of lipids or degradation products of lipids in the artery wall. The hypothesis states that platelet interactions and macrophage interactions in an injured artery provide potential opportunities for release of at least two growth factors: the platelet-derived growth factor (PDGFJ3 and the macrophage-derived growth factor (MDGF), 4 into the artery wall at sites of injury. The platelet-derived growth factor has been demonstrated in Boyden chamber experiments to be chemotactic for smooth muscle cells5 and fibroblasts. 6 It is also possible that MDGF may be chemotactic. If this were true in vivo, the hypothesis suggests that the release of these growth factors into the artery wall could provide opportunities for smooth muscle cells to be attracted from the media into the intima, and to undergo a proliferative response that would lead to the development of a fibromusculoelastic proliferative lesion, a precursor lesion to those classically associated with atherosclerosis, namely the fibrous plaque.